Showing 8021-8030 of 18600 results for "".
Cases From The Real World: A Long Battle With BRVO-ME
https://reachmd.com/programs/cme/Cases-From-The-Real-World-A-Long-Battle-With-BRVO-ME/33170/Join Drs. Yasha Modi and Ferhina Ali as they dive into the challenges of treating RVO-ME and the effectiveness of traditional and emerging agents.Lupus Management Considerations for African American Patients
https://reachmd.com/programs/everyday-family-medicine/lupus-management-considerations-for-african-american-patients/10132/With more African Americans experiencing severe lupus symptoms, Drs. Jennifer Caudle and Ashira Blazer provide some much-needed treatment advice.Applying CBT for Psychosis in Schizophrenia Care: Strategies for Expanding Access
https://reachmd.com/programs/neurofrontiers/applying-cbt-for-psychosis-in-schizophrenia-care-strategies-for-expanding-access/36647/Despite decades of evidence supporting cognitive behavioral therapy (CBT) for psychosis, most patients with schizophrenia in the U.S. never receive it due to systemic barriers like provider shortages and fragmented transitions after hospitalization. To address these gaps, Dr. David Kimhy joins Dr. CUnderstanding Endocrine Resistance in HR+/HER2- mBC
https://reachmd.com/programs/cme/Understanding-Endocrine-Resistance-in-HR-HER2-mBC/37323/Join Drs. Jhaveri and Kalinsky and get up to speed on the latest data on PI3K-directed therapies and their role in the treatment paradigm for HR+, HER2- mBC.Navigating Nail Psoriasis: Treatment Strategies for Patient-Centered Care
https://reachmd.com/programs/clinicians-roundtable/navigating-nail-psoriasis-treatment-strategies-for-patient-centered-care/32867/Explore expert recommendations and long-term management strategies for nail psoriasis.Treatment of OAB and the Managed Care Professional: Balancing the Double-Edged Sword
https://reachmd.com/programs/cme/treatment-of-oab-and-the-managed-care-professional-balancing-the-double-edged-sword/15362/Are you prepared to actively engage with your patients about their overactive bladder?Rozanolixizumab for Myasthenia Gravis: An Alternative to Corticosteroids
https://reachmd.com/programs/neurofrontiers/rozanolixizumab-for-myasthenia-gravis-an-alternative-to-corticosteroids/30069/Here’s how rozanolixizumab compares to other treatment options for myasthenia gravis.Exploring Lateral Wall Collapse and Hypoglossal Nerve Stimulation in OSA
https://reachmd.com/programs/clinicians-roundtable/exploring-lateral-wall-collapse-and-hypoglossal-nerve-stimulation-in-osa/35654/A recent study explored whether lateral wall collapse can predict hypoglossal nerve stimulation efficacy in patients with obstructive sleep apnea (OSA). Join Dr. Daniel Vena as he explains the findings from this research and areas for future explanation. Dr. Vena is an Assistant Professor of MedicinUnderstanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
https://reachmd.com/programs/Audioabstracts/understanding-safety-profiles-of-ros1-tkis-in-advanced-non-small-cell-lung-cancer/54576/Targeted therapies have transformed care for patients with ROS1-rearranged advanced non-small cell lung cancer, but long-term treatment makes safety and tolerability critical. In this AudioAbstract, Ryan Quigley breaks down a 2025 systematic review examining toxicity profiles across seven ROS1 tyrosRecognizing PSO-HS as a Distinct Subset with Shared Genetic Risk
https://reachmd.com/programs/dermconsult/pso-hs-subset-genetic-risk/39676/